{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:44:53Z","timestamp":1790948693806,"version":"4.1.0"},"reference-count":177,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s43032-024-01454-6","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T20:02:01Z","timestamp":1709236921000},"page":"2588-2603","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Multiple Functions of HB-EGF in Female Reproduction and Related Cancer: Molecular Mechanisms and Targeting Strategies"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8883-2693","authenticated-orcid":false,"given":"Yuwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lujia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"issue":"4996","key":"1454_CR1","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1126\/science.1840698","volume":"251","author":"S Higashiyama","year":"1991","unstructured":"Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science. 1991;251(4996):936\u20139.","journal-title":"Science."},{"issue":"4","key":"1454_CR2","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1016\/S0021-9258(17)41979-X","volume":"269","author":"SA Thompson","year":"1994","unstructured":"Thompson SA, Higashiyama S, Wood K, Pollitt NS, Damm D, McEnroe G, Garrick B, Ashton N, Lau K, Hancock N, et al. Characterization of sequences within heparin-binding EGF-like growth factor that mediate interaction with heparin. J Biol Chem. 1994;269(4):2541\u20139.","journal-title":"J Biol Chem."},{"issue":"1","key":"1454_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/BF00694752","volume":"35","author":"HS Earp","year":"1995","unstructured":"Earp HS, Dawson TL, Li X, Yu H. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res Treat. 1995;35(1):115\u201332.","journal-title":"Breast Cancer Res Treat."},{"issue":"13","key":"1454_CR4","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1073\/pnas.87.13.4905","volume":"87","author":"GD Plowman","year":"1990","unstructured":"Plowman GD, Whitney GS, Neubauer MG, Green JM, McDonald VL, Todaro GJ, Shoyab M. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc Natl Acad Sci U S A. 1990;87(13):4905\u20139.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"1454_CR5","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1073\/pnas.90.5.1746","volume":"90","author":"GD Plowman","year":"1993","unstructured":"Plowman GD, Culouscou JM, Whitney GS, Green JM, Carlton GW, Foy L, Neubauer MG, Shoyab M. Ligand-specific activation of HER4\/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci U S A. 1993;90(5):1746\u201350.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"9","key":"1454_CR6","doi-asserted-by":"publisher","first-page":"6205","DOI":"10.1016\/S0021-9258(18)42682-8","volume":"267","author":"S Higashiyama","year":"1992","unstructured":"Higashiyama S, Lau K, Besner GE, Abraham JA, Klagsbrun M. Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein. J Biol Chem. 1992;267(9):6205\u201312.","journal-title":"J Biol Chem."},{"issue":"6","key":"1454_CR7","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/emboj\/16.6.1268","volume":"16","author":"K Elenius","year":"1997","unstructured":"Elenius K, Paul S, Allison G, Sun J, Klagsbrun M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 1997;16(6):1268\u201378.","journal-title":"EMBO J."},{"issue":"42","key":"1454_CR8","doi-asserted-by":"publisher","first-page":"26761","DOI":"10.1074\/jbc.272.42.26761","volume":"272","author":"K Elenius","year":"1997","unstructured":"Elenius K, Corfas G, Paul S, Choi CJ, Rio C, Plowman GD, Klagsbrun M. A novel juxtamembrane domain isoform of HER4\/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J Biol Chem. 1997;272(42):26761\u20138.","journal-title":"J Biol Chem."},{"issue":"1","key":"1454_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0092-8674(94)90564-9","volume":"78","author":"KL Carraway 3rd","year":"1994","unstructured":"Carraway KL 3rd, Cantley LC. A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell. 1994;78(1):5\u20138.","journal-title":"Cell."},{"issue":"4","key":"1454_CR10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1083\/jcb.122.4.933","volume":"122","author":"S Higashiyama","year":"1993","unstructured":"Higashiyama S, Abraham JA, Klagsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J Cell Biol. 1993;122(4):933\u201340.","journal-title":"J Cell Biol."},{"issue":"49","key":"1454_CR11","doi-asserted-by":"publisher","first-page":"29578","DOI":"10.1074\/jbc.270.49.29578","volume":"270","author":"Y Shishido","year":"1995","unstructured":"Shishido Y, Sharma KD, Higashiyama S, Klagsbrun M, Mekada E. Heparin-like molecules on the cell surface potentiate binding of diphtheria toxin to the diphtheria toxin receptor\/membrane-anchored heparin-binding epidermal growth factor-like growth factor. J Biol Chem. 1995;270(49):29578\u201385.","journal-title":"J Biol Chem."},{"issue":"25","key":"1454_CR12","doi-asserted-by":"publisher","first-page":"12173","DOI":"10.1073\/pnas.91.25.12173","volume":"91","author":"D Aviezer","year":"1994","unstructured":"Aviezer D, Yayon A. Heparin-dependent binding and autophosphorylation of epidermal growth factor (EGF) receptor by heparin-binding EGF-like growth factor but not by EGF. Proc Natl Acad Sci U S A. 1994;91(25):12173\u20137.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"1454_CR13","first-page":"F179","volume":"1333","author":"G Raab","year":"1997","unstructured":"Raab G, Klagsbrun M. Heparin-binding EGF-like growth factor. Biochim Biophys Acta. 1997;1333(3):F179\u201399.","journal-title":"Biochim Biophys Acta."},{"key":"1454_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1146\/annurev.bi.62.070193.002503","volume":"62","author":"J Massague","year":"1993","unstructured":"Massague J, Pandiella A. Membrane-anchored growth factors. Annu Rev Biochem. 1993;62:515\u201341.","journal-title":"Annu Rev Biochem."},{"issue":"8","key":"1454_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1091\/mbc.6.8.967","volume":"6","author":"K Goishi","year":"1995","unstructured":"Goishi K, Higashiyama S, Klagsbrun M, Nakano N, Umata T, Ishikawa M, Mekada E, Taniguchi N. Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity. Mol Biol Cell. 1995;6(8):967\u201380.","journal-title":"Mol Biol Cell."},{"issue":"24","key":"1454_CR16","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1093\/emboj\/17.24.7260","volume":"17","author":"Y Izumi","year":"1998","unstructured":"Izumi Y, Hirata M, Hasuwa H, Iwamoto R, Umata T, Miyado K, Tamai Y, Kurisaki T, Sehara-Fujisawa A, Ohno S, Mekada E. A metalloprotease-disintegrin, MDC9\/meltrin-gamma\/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 1998;17(24):7260\u201372.","journal-title":"EMBO J."},{"issue":"2","key":"1454_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1242\/dev.122.2.637","volume":"122","author":"G Raab","year":"1996","unstructured":"Raab G, Kover K, Paria BC, Dey SK, Ezzell RM, Klagsbrun M. Mouse preimplantation blastocysts adhere to cells expressing the transmembrane form of heparin-binding EGF-like growth factor. Development. 1996;122(2):637\u201345.","journal-title":"Development."},{"issue":"6","key":"1454_CR18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1083\/jcb.129.6.1691","volume":"129","author":"K Nakamura","year":"1995","unstructured":"Nakamura K, Iwamoto R, Mekada E. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)\/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J Cell Biol. 1995;129(6):1691\u2013705.","journal-title":"J Cell Biol."},{"issue":"2","key":"1454_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1083\/jcb.107.2.511","volume":"107","author":"E Mekada","year":"1988","unstructured":"Mekada E, Okada Y, Uchida T. Identification of diphtheria toxin receptor and a nonproteinous diphtheria toxin-binding molecule in Vero cell membrane. J Cell Biol. 1988;107(2):511\u20139.","journal-title":"J Cell Biol."},{"issue":"6","key":"1454_CR20","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/0092-8674(92)90623-K","volume":"69","author":"JG Naglich","year":"1992","unstructured":"Naglich JG, Metherall JE, Russell DW, Eidels L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell. 1992;69(6):1051\u201361.","journal-title":"Cell."},{"issue":"5","key":"1454_CR21","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1083\/jcb.128.5.929","volume":"128","author":"S Higashiyama","year":"1995","unstructured":"Higashiyama S, Iwamoto R, Goishi K, Raab G, Taniguchi N, Klagsbrun M, Mekada E. The membrane protein CD9\/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor. J Cell Biol. 1995;128(5):929\u201338.","journal-title":"J Cell Biol."},{"issue":"30","key":"1454_CR22","doi-asserted-by":"publisher","first-page":"20463","DOI":"10.1016\/S0021-9258(18)54947-4","volume":"266","author":"R Iwamoto","year":"1991","unstructured":"Iwamoto R, Senoh H, Okada Y, Uchida T, Mekada E. An antibody that inhibits the binding of diphtheria toxin to cells revealed the association of a 27-kDa membrane protein with the diphtheria toxin receptor. J Biol Chem. 1991;266(30):20463\u20139.","journal-title":"J Biol Chem."},{"issue":"10","key":"1454_CR23","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1002\/j.1460-2075.1994.tb06516.x","volume":"13","author":"R Iwamoto","year":"1994","unstructured":"Iwamoto R, Higashiyama S, Mitamura T, Taniguchi N, Klagsbrun M, Mekada E. Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27\/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity. EMBO J. 1994;13(10):2322\u201330.","journal-title":"EMBO J."},{"issue":"Pt 1","key":"1454_CR24","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1042\/bj3100285","volume":"310","author":"M Lanzrein","year":"1995","unstructured":"Lanzrein M, Garred O, Olsnes S, Sandvig K. Diphtheria toxin endocytosis and membrane translocation are dependent on the intact membrane-anchored receptor (HB-EGF precursor): studies on the cell-associated receptor cleaved by a metalloprotease in phorbol-ester-treated cells. Biochem J. 1995;310(Pt 1):285\u20139.","journal-title":"Biochem J."},{"issue":"2","key":"1454_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1083\/jcb.201209151","volume":"201","author":"B Diaz","year":"2013","unstructured":"Diaz B, Yuen A, Iizuka S, Higashiyama S, Courtneidge SA. Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia. J Cell Biol. 2013;201(2):279\u201392.","journal-title":"J Cell Biol."},{"issue":"2","key":"1454_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/jbmr.3596","volume":"34","author":"P Li","year":"2019","unstructured":"Li P, Deng Q, Liu J, Yan J, Wei Z, Zhang Z, Liu H, Li B. Roles for HB-EGF in mesenchymal stromal cell proliferation and differentiation during skeletal growth. J Bone Miner Res. 2019;34(2):295\u2013309.","journal-title":"J Bone Miner Res."},{"issue":"6","key":"1454_CR27","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/jnc.12519","volume":"128","author":"TB Puschmann","year":"2014","unstructured":"Puschmann TB, Zanden C, Lebkuechner I, Philippot C, de Pablo Y, Liu J, Pekny M. HB-EGF affects astrocyte morphology, proliferation, differentiation, and the expression of intermediate filament proteins. J Neurochem. 2014;128(6):878\u201389.","journal-title":"J Neurochem."},{"issue":"20","key":"1454_CR28","doi-asserted-by":"publisher","first-page":"e2302937120","DOI":"10.1073\/pnas.2302937120","volume":"120","author":"YS Kim","year":"2023","unstructured":"Kim YS, Yuan J, Dewar A, Borg JP, Threadgill DW, Sun X, Dey SK. An unanticipated discourse of HB-EGF with VANGL2 signaling during embryo implantation. Proc Natl Acad Sci U S A. 2023;120(20):e2302937120.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"1454_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1530\/JOE-16-0636","volume":"234","author":"J Liu","year":"2017","unstructured":"Liu J, Gao F, Liu YF, Dou HT, Yan JQ, Fan ZM, Yang ZM. HB-EGF regulates Prss56 expression during mouse decidualization via EGFR\/ERK\/EGR2 signaling pathway. J Endocrinol. 2017;234(3):247\u201354.","journal-title":"J Endocrinol."},{"issue":"17","key":"1454_CR30","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1242\/dev.129.17.4125","volume":"129","author":"X Wang","year":"2002","unstructured":"Wang X, Wang H, Matsumoto H, Roy SK, Das SK, Paria BC. Dual source and target of heparin-binding EGF-like growth factor during the onset of implantation in the hamster. Development. 2002;129(17):4125\u201334.","journal-title":"Development."},{"issue":"5","key":"1454_CR31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1439-0531.2008.01082.x","volume":"44","author":"YJ Kim","year":"2009","unstructured":"Kim YJ, Lee GS, Hyun SH, Ka HH, Choi KC, Lee CK, Jeung EB. Uterine expression of epidermal growth factor family during the course of pregnancy in pigs. Reprod Domest Anim. 2009;44(5):797\u2013804.","journal-title":"Reprod Domest Anim."},{"issue":"3","key":"1454_CR32","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1095\/biolreprod52.3.561","volume":"52","author":"GY Kim","year":"1995","unstructured":"Kim GY, Besner GE, Steffen CL, McCarthy DW, Downing MT, Luquette MH, Abad MS, Brigstock DR. Purification of heparin-binding epidermal growth factor-like growth factor from pig uterine luminal flushings, and its production by endometrial tissues. Biol Reprod. 1995;52(3):561\u201371.","journal-title":"Biol Reprod."},{"issue":"4","key":"1454_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/(SICI)1098-2795(199812)51:4<402::AID-MRD7>3.0.CO;2-9","volume":"51","author":"A Kliem","year":"1998","unstructured":"Kliem A, Tetens F, Klonisch T, Grealy M, Fischer B. Epidermal growth factor receptor and ligands in elongating bovine blastocysts. Mol Reprod Dev. 1998;51(4):402\u201312.","journal-title":"Mol Reprod Dev."},{"issue":"3","key":"1454_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/rda.12513","volume":"50","author":"K Takatsu","year":"2015","unstructured":"Takatsu K, Acosta TJ. Expression of heparin-binding EGF-like growth factor (HB-EGF) in bovine endometrium: effects of HB-EGF and interferon-tau on prostaglandin production. Reprod Domest Anim. 2015;50(3):458\u201364.","journal-title":"Reprod Domest Anim."},{"issue":"6","key":"1454_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1262\/jrd.17039","volume":"51","author":"DS Lee","year":"2005","unstructured":"Lee DS, Yanagimoto Ueta Y, Xuan X, Igarashi I, Fujisaki K, Sugimoto C, Toyoda Y, Suzuki H. Expression patterns of the implantation-associated genes in the uterus during the estrous cycle in mice. J Reprod Dev. 2005;51(6):787\u201398.","journal-title":"J Reprod Dev."},{"issue":"5","key":"1454_CR36","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1242\/dev.120.5.1071","volume":"120","author":"SK Das","year":"1994","unstructured":"Das SK, Wang XN, Paria BC, Damm D, Abraham JA, Klagsbrun M, Andrews GK, Dey SK. Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development. 1994;120(5):1071\u201383.","journal-title":"Development."},{"issue":"4","key":"1454_CR37","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/mrd.10129","volume":"62","author":"BA Lessey","year":"2002","unstructured":"Lessey BA, Gui Y, Apparao KB, Young SL, Mulholland J. Regulated expression of heparin-binding EGF-like growth factor (HB-EGF) in the human endometrium: a potential paracrine role during implantation. Mol Reprod Dev. 2002;62(4):446\u201355.","journal-title":"Mol Reprod Dev."},{"issue":"1","key":"1454_CR38","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/(SICI)1520-6408(1997)21:1<102::AID-DVG12>3.0.CO;2-C","volume":"21","author":"HJ Yoo","year":"1997","unstructured":"Yoo HJ, Barlow DH, Mardon HJ. Temporal and spatial regulation of expression of heparin-binding epidermal growth factor-like growth factor in the human endometrium: a possible role in blastocyst implantation. Dev Genet. 1997;21(1):102\u20138.","journal-title":"Dev Genet."},{"issue":"9","key":"1454_CR39","first-page":"3355","volume":"84","author":"RE Leach","year":"1999","unstructured":"Leach RE, Khalifa R, Ramirez ND, Das SK, Wang J, Dey SK, Romero R, Armant DR. Multiple roles for heparin-binding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrial cycle and early placentation. J Clin Endocrinol Metab. 1999;84(9):3355\u201363.","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"1454_CR40","doi-asserted-by":"publisher","first-page":"5769","DOI":"10.1210\/jc.2002-020069","volume":"87","author":"K Chobotova","year":"2002","unstructured":"Chobotova K, Muchmore ME, Carver J, Yoo HJ, Manek S, Gullick WJ, Barlow DH, Mardon HJ. The mitogenic potential of heparin-binding epidermal growth factor in the human endometrium is mediated by the epidermal growth factor receptor and is modulated by tumor necrosis factor-alpha. J Clin Endocrinol Metab. 2002;87(12):5769\u201377.","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"1454_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/molehr\/2.1.31","volume":"2","author":"MA Birdsall","year":"1996","unstructured":"Birdsall MA, Hopkisson JF, Grant KE, Barlow DH, Mardon HJ. Expression of heparin-binding epidermal growth factor messenger RNA in the human endometrium. Mol Hum Reprod. 1996;2(1):31\u20134.","journal-title":"Mol Hum Reprod."},{"issue":"1-4","key":"1454_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.prostaglandins.2004.09.013","volume":"77","author":"H Wang","year":"2005","unstructured":"Wang H, Dey SK. Lipid signaling in embryo implantation. Prostaglandins Other Lipid Mediat. 2005;77(1-4):84\u2013102.","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"7","key":"1454_CR43","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/humrep\/deac112","volume":"37","author":"PI Deryabin","year":"2022","unstructured":"Deryabin PI, Borodkina AV. Stromal cell senescence contributes to impaired endometrial decidualization and defective interaction with trophoblast cells. Hum Reprod. 2022;37(7):1505\u201324.","journal-title":"Hum Reprod."},{"issue":"3","key":"1454_CR44","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1210\/endo.135.3.8070372","volume":"135","author":"XN Wang","year":"1994","unstructured":"Wang XN, Das SK, Damm D, Klagsbrun M, Abraham JA, Dey SK. Differential regulation of heparin-binding epidermal growth factor-like growth factor in the adult ovariectomized mouse uterus by progesterone and estrogen. Endocrinology. 1994;135(3):1264\u201371.","journal-title":"Endocrinology."},{"issue":"3","key":"1454_CR45","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1210\/endo.134.3.8119147","volume":"134","author":"Z Zhang","year":"1994","unstructured":"Zhang Z, Funk C, Roy D, Glasser S, Mulholland J. Heparin-binding epidermal growth factor-like growth factor is differentially regulated by progesterone and estradiol in rat uterine epithelial and stromal cells. Endocrinology. 1994;134(3):1089\u201394.","journal-title":"Endocrinology."},{"issue":"21","key":"1454_CR46","doi-asserted-by":"publisher","first-page":"10159","DOI":"10.1073\/pnas.90.21.10159","volume":"90","author":"BC Paria","year":"1993","unstructured":"Paria BC, Huet-Hudson YM, Dey SK. Blastocyst\u2019s state of activity determines the \u201cwindow\u201d of implantation in the receptive mouse uterus. Proc Natl Acad Sci U S A. 1993;90(21):10159\u201362.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"11","key":"1454_CR47","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1590\/S0100-879X2006001100001","volume":"39","author":"WA Castro-Rendon","year":"2006","unstructured":"Castro-Rendon WA, Castro-Alvarez JF, Guzman-Martinez C, Bueno-Sanchez JC. Blastocyst-endometrium interaction: intertwining a cytokine network. Braz J Med Biol Res. 2006;39(11):1373\u201385.","journal-title":"Braz J Med Biol Res."},{"issue":"3","key":"1454_CR48","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1055\/s-2000-12565","volume":"18","author":"DR Armant","year":"2000","unstructured":"Armant DR, Wang J, Liu Z. Intracellular signaling in the developing blastocyst as a consequence of the maternal-embryonic dialogue. Semin Reprod Med. 2000;18(3):273\u201387.","journal-title":"Semin Reprod Med."},{"issue":"3","key":"1454_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1472-6483(10)61945-1","volume":"1","author":"A Mishra","year":"2000","unstructured":"Mishra A, Seshagiri PB. Heparin binding-epidermal growth factor improves blastocyst hatching and trophoblast outgrowth in the golden hamster. Reprod Biomed Online. 2000;1(3):87\u201395.","journal-title":"Reprod Biomed Online."},{"issue":"1","key":"1454_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ydbio.2003.09.019","volume":"265","author":"Y Tan","year":"2004","unstructured":"Tan Y, Li M, Cox S, Davis MK, Tawfik O, Paria BC, Das SK. HB-EGF directs stromal cell polyploidy and decidualization via cyclin D3 during implantation. Dev Biol. 2004;265(1):181\u201395.","journal-title":"Dev Biol."},{"issue":"1-2","key":"1454_CR51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0925-4773(01)00614-1","volume":"111","author":"J Tan","year":"2002","unstructured":"Tan J, Raja S, Davis MK, Tawfik O, Dey SK, Das SK. Evidence for coordinated interaction of cyclin D3 with p21 and cdk6 in directing the development of uterine stromal cell decidualization and polyploidy during implantation. Mech Dev. 2002;111(1-2):99\u2013113.","journal-title":"Mech Dev."},{"key":"1454_CR52","first-page":"927631","volume":"10","author":"J Afzal","year":"2022","unstructured":"Afzal J, Du W, Novin A, Liu Y, Wali K, Murthy A, Garen A, Wagner G. Kshitiz, Paracrine HB-EGF signaling reduce enhanced contractile and energetic state of activated decidual fibroblasts by rebalancing SRF-MRTF-TCF transcriptional axis, Front Cell. Dev Biol. 2022;10:927631.","journal-title":"Dev Biol."},{"issue":"2","key":"1454_CR53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1083\/jcb.200204026","volume":"158","author":"M Umezu-Goto","year":"2002","unstructured":"Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, Arai H. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol. 2002;158(2):227\u201333.","journal-title":"J Cell Biol."},{"issue":"2","key":"1454_CR54","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/jb\/mvu077","volume":"157","author":"S Aikawa","year":"2015","unstructured":"Aikawa S, Hashimoto T, Kano K, Aoki J. Lysophosphatidic acid as a lipid mediator with multiple biological actions. J Biochem. 2015;157(2):81\u20139.","journal-title":"J Biochem."},{"issue":"14","key":"1454_CR55","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.15252\/embj.201696290","volume":"36","author":"S Aikawa","year":"2017","unstructured":"Aikawa S, Kano K, Inoue A, Wang J, Saigusa D, Nagamatsu T, Hirota Y, Fujii T, Tsuchiya S, Taketomi Y, Sugimoto Y, Murakami M, Arita M, Kurano M, Ikeda H, Yatomi Y, Chun J, Aoki J. Autotaxin-lysophosphatidic acid-LPA(3) signaling at the embryo-epithelial boundary controls decidualization pathways. EMBO J. 2017;36(14):2146\u201360.","journal-title":"EMBO J."},{"issue":"2","key":"1454_CR56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.yexcr.2004.02.006","volume":"296","author":"Z Liu","year":"2004","unstructured":"Liu Z, Armant DR. Lysophosphatidic acid regulates murine blastocyst development by transactivation of receptors for heparin-binding EGF-like growth factor. Exp Cell Res. 2004;296(2):317\u201326.","journal-title":"Exp Cell Res."},{"key":"1454_CR57","doi-asserted-by":"publisher","first-page":"1024706","DOI":"10.3389\/fimmu.2023.1024706","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Chen ST, He YY, Li B, Yang C, Yang ZS, Yang ZM. The regulation and function of acetylated high-mobility group box 1 during implantation and decidualization. Front Immunol. 2023;14:1024706.","journal-title":"Front Immunol."},{"issue":"22","key":"1454_CR58","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/S0024-3205(99)00128-9","volume":"64","author":"H Tamada","year":"1999","unstructured":"Tamada H, Higashiyama C, Takano H, Kawate N, Inaba T, Sawada T. The effects of heparin-binding epidermal growth factor-like growth factor on preimplantation-embryo development and implantation in the rat. Life Sci. 1999;64(22):1967\u201373.","journal-title":"Life Sci."},{"issue":"7","key":"1454_CR59","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/molehr\/gar015","volume":"17","author":"M Gonzalez","year":"2011","unstructured":"Gonzalez M, Neufeld J, Reimann K, Wittmann S, Samalecos A, Wolf A, Bamberger AM, Gellersen B. Expansion of human trophoblastic spheroids is promoted by decidualized endometrial stromal cells and enhanced by heparin-binding epidermal growth factor-like growth factor and interleukin-1 beta. Mol Hum Reprod. 2011;17(7):421\u201333.","journal-title":"Mol Hum Reprod."},{"issue":"3","key":"1454_CR60","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/1933719116657893","volume":"24","author":"CX Fang","year":"2017","unstructured":"Fang CX, Nong YQ, Liu FH, Fan L, Chen Y. Heparin-binding epidermal growth factor-like growth factor enhances aquaporin 3 expression and function during mouse embryo implantation. Reprod Sci. 2017;24(3):463\u201370.","journal-title":"Reprod Sci."},{"issue":"4","key":"1454_CR61","first-page":"599","volume":"19","author":"F Moghani-Ghoroghi","year":"2018","unstructured":"Moghani-Ghoroghi F, Moshkdanian G, Sehat M, Nematollahi-Mahani SN, Ragerdi-Kashani I, Pasbakhsh P. Melatonin pretreated blastocysts along with calcitonin administration improved implantation by upregulation of heparin binding-epidermal growth factor expression in murine endometrium. Cell J. 2018;19(4):599\u2013606.","journal-title":"Cell J."},{"issue":"3","key":"1454_CR62","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/jpi.12216","volume":"58","author":"C He","year":"2015","unstructured":"He C, Wang J, Li Y, Zhu K, Xu Z, Song Y, Song Y, Liu G. Melatonin-related genes expressed in the mouse uterus during early gestation promote embryo implantation. J Pineal Res. 2015;58(3):300\u20139.","journal-title":"J Pineal Res."},{"issue":"9","key":"1454_CR63","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/clc.4960130905","volume":"13","author":"HG Stratmann","year":"1990","unstructured":"Stratmann HG, Mark AL, Williams GA. Thallium-201 perfusion imaging with atrial pacing or dipyridamole stress testing for evaluation of cardiac risk prior to nonvascular surgery. Clin Cardiol. 1990;13(9):611\u20136.","journal-title":"Clin Cardiol."},{"issue":"11","key":"1454_CR64","doi-asserted-by":"publisher","first-page":"20098","DOI":"10.1002\/jcp.28609","volume":"234","author":"MB Hesam Shariati","year":"2019","unstructured":"Hesam Shariati MB, Seghinsara AM, Shokrzadeh N, Niknafs B. The effect of fludrocortisone on the uterine receptivity partially mediated by ERK1\/2-mTOR pathway. J Cell Physiol. 2019;234(11):20098\u2013110.","journal-title":"J Cell Physiol."},{"issue":"3","key":"1454_CR65","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1073\/pnas.98.3.1047","volume":"98","author":"BC Paria","year":"2001","unstructured":"Paria BC, Ma W, Tan J, Raja S, Das SK, Dey SK, Hogan BL. Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors. Proc Natl Acad Sci U S A. 2001;98(3):1047\u201352.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"1454_CR66","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/jez.b.22807","volume":"330","author":"L Yue","year":"2018","unstructured":"Yue L, Yu HF, Yang ZQ, Tian XC, Zheng LW, Guo B. Egr2 mediates the differentiation of mouse uterine stromal cells responsiveness to HB-EGF during decidualization. J Exp Zool B Mol Dev Evol. 2018;330(4):215\u201324.","journal-title":"J Exp Zool B Mol Dev Evol."},{"key":"1454_CR67","doi-asserted-by":"publisher","first-page":"6170936","DOI":"10.1155\/2019\/6170936","volume":"2019","author":"HF Yu","year":"2019","unstructured":"Yu HF, Duan CC, Yang ZQ, Wang YS, Yue ZP, Guo B. HB-EGF ameliorates oxidative stress-mediated uterine decidualization damage. Oxid Med Cell Longev. 2019;2019:6170936.","journal-title":"Oxid Med Cell Longev."},{"issue":"5737","key":"1454_CR68","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1126\/science.1110955","volume":"309","author":"JH Hong","year":"2005","unstructured":"Hong JH, Hwang ES, McManus MT, Amsterdam A, Tian Y, Kalmukova R, Mueller E, Benjamin T, Spiegelman BM, Sharp PA, Hopkins N, Yaffe MB. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science. 2005;309(5737):1074\u20138.","journal-title":"Science."},{"issue":"4","key":"1454_CR69","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell. 2015;163(4):811\u201328.","journal-title":"Cell."},{"issue":"9","key":"1454_CR70","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/s12276-021-00655-2","volume":"53","author":"HF Yu","year":"2021","unstructured":"Yu HF, Zheng LW, Yang ZQ, Wang YS, Wang TT, Yue ZP, Guo B. TAZ as a novel regulator of oxidative damage in decidualization via Nrf2\/ARE\/Foxo1 pathway. Exp Mol Med. 2021;53(9):1307\u201318.","journal-title":"Exp Mol Med."},{"key":"1454_CR71","doi-asserted-by":"publisher","first-page":"119222","DOI":"10.1016\/j.envpol.2022.119222","volume":"304","author":"ZY Jin","year":"2022","unstructured":"Jin ZY, Liu CK, Hong YQ, Liang YX, Liu L, Yang ZM. BHPF exposure impairs mouse and human decidualization. Environ Pollut. 2022;304:119222.","journal-title":"Environ Pollut."},{"issue":"1-2","key":"1454_CR72","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.mce.2013.08.011","volume":"381","author":"XH Zhang","year":"2013","unstructured":"Zhang XH, Liang X, Wang TS, Liang XH, Zuo RJ, Deng WB, Zhang ZR, Qin FN, Zhao ZA, Yang ZM. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) induction on Snail expression during mouse decidualization. Mol Cell Endocrinol. 2013;381(1-2):272\u20139.","journal-title":"Mol Cell Endocrinol."},{"issue":"12","key":"1454_CR73","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1080\/15384101.2015.1033593","volume":"14","author":"QR Qi","year":"2015","unstructured":"Qi QR, Zhao XY, Zuo RJ, Wang TS, Gu XW, Liu JL, Yang ZM. Involvement of atypical transcription factor E2F8 in the polyploidization during mouse and human decidualization. Cell Cycle. 2015;14(12):1842\u201358.","journal-title":"Cell Cycle."},{"issue":"3","key":"1454_CR74","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1096\/fj.201902289R","volume":"34","author":"HF Yu","year":"2020","unstructured":"Yu HF, Duan CC, Yang ZQ, Wang YS, Yue ZP, Guo B. Malic enzyme 1 is important for uterine decidualization in response to progesterone\/cAMP\/PKA\/HB-EGF pathway. FASEB J. 2020;34(3):3820\u201337.","journal-title":"FASEB J."},{"issue":"7","key":"1454_CR75","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1210\/en.2006-1383","volume":"148","author":"Y Wang","year":"2007","unstructured":"Wang Y, Li J, Ying Wang C, Yan Kwok AH, Leung FC. Epidermal growth factor (EGF) receptor ligands in the chicken ovary: I. Evidence for heparin-binding EGF-like growth factor (HB-EGF) as a potential oocyte-derived signal to control granulosa cell proliferation and HB-EGF and kit ligand expression. Endocrinology. 2007;148(7):3426\u201340.","journal-title":"Endocrinology."},{"issue":"1-2","key":"1454_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2003.12.003","volume":"214","author":"B Pan","year":"2004","unstructured":"Pan B, Sengoku K, Takuma N, Goishi K, Horikawa M, Tamate K, Ishikawa M. Differential expression of heparin-binding epidermal growth factor-like growth factor in the rat ovary. Mol Cell Endocrinol. 2004;214(1-2):1\u20138.","journal-title":"Mol Cell Endocrinol."},{"issue":"10","key":"1454_CR77","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1093\/humrep\/dei162","volume":"20","author":"Y Akayama","year":"2005","unstructured":"Akayama Y, Takekida S, Ohara N, Tateiwa H, Chen W, Nakabayashi K, Maruo T. Gene expression and immunolocalization of heparin-binding epidermal growth factor-like growth factor and human epidermal growth factor receptors in human corpus luteum. Hum Reprod. 2005;20(10):2708\u201314.","journal-title":"Hum Reprod."},{"issue":"Suppl 1","key":"1454_CR78","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.ejogrb.2004.01.010","volume":"115","author":"S Cecconi","year":"2004","unstructured":"Cecconi S, Ciccarelli C, Barberi M, Macchiarelli G, Canipari R. Granulosa cell-oocyte interactions. Eur J Obstet Gynecol Reprod Biol. 2004;115(Suppl 1):S19\u201322.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"issue":"3","key":"1454_CR79","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/humupd\/6.3.279","volume":"6","author":"R Canipari","year":"2000","unstructured":"Canipari R. Oocyte--granulosa cell interactions. Hum Reprod Update. 2000;6(3):279\u201389.","journal-title":"Hum Reprod Update."},{"issue":"8","key":"1454_CR80","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/molehr\/8.8.734","volume":"8","author":"B Pan","year":"2002","unstructured":"Pan B, Sengoku K, Goishi K, Takuma N, Yamashita T, Wada K, Ishikawa M. The soluble and membrane-anchored forms of heparin-binding epidermal growth factor-like growth factor appear to play opposing roles in the survival and apoptosis of human luteinized granulosa cells. Mol Hum Reprod. 2002;8(8):734\u201341.","journal-title":"Mol Hum Reprod."},{"issue":"6","key":"1454_CR81","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3109\/08977194.2011.607136","volume":"29","author":"S Karakida","year":"2011","unstructured":"Karakida S, Kawano Y, Utsunomiya Y, Furukawa Y, Sasaki T, Narahara H. Effect of heparin-binding EGF-like growth factor and amphiregulin on the MAP kinase-induced production of vascular endothelial growth factor by human granulosa cells. Growth Factors. 2011;29(6):271\u20137.","journal-title":"Growth Factors."},{"issue":"45","key":"1454_CR82","doi-asserted-by":"publisher","first-page":"28314","DOI":"10.1016\/S0021-9258(18)46930-X","volume":"269","author":"BJ Clark","year":"1994","unstructured":"Clark BJ, Wells J, King SR, Stocco DM. The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem. 1994;269(45):28314\u201322.","journal-title":"J Biol Chem."},{"issue":"3","key":"1454_CR83","first-page":"221","volume":"17","author":"DM Stocco","year":"1996","unstructured":"Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev. 1996;17(3):221\u201344.","journal-title":"Endocr Rev."},{"issue":"1","key":"1454_CR84","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12964-022-00983-4","volume":"20","author":"JC Cheng","year":"2022","unstructured":"Cheng JC, Han X, Meng Q, Guo Y, Liu B, Song T, Jia Y, Fang L, Sun YP. HB-EGF upregulates StAR expression and stimulates progesterone production through ERK1\/2 signaling in human granulosa-lutein cells. Cell Commun Signal. 2022;20(1):166.","journal-title":"Cell Commun Signal."},{"key":"1454_CR85","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gene.2018.10.006","volume":"683","author":"T Wang","year":"2019","unstructured":"Wang T, Liu Y, Lv M, Xing Q, Zhang Z, He X, Xu Y, Wei Z, Cao Y. miR-323-3p regulates the steroidogenesis and cell apoptosis in polycystic ovary syndrome (PCOS) by targeting IGF-1. Gene. 2019;683:87\u2013100.","journal-title":"Gene."},{"issue":"15","key":"1454_CR86","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1073\/pnas.1418216112","volume":"112","author":"F Wang","year":"2015","unstructured":"Wang F, Pan J, Liu Y, Meng Q, Lv P, Qu F, Ding GL, Klausen C, Leung PC, Chan HC, Yao W, Zhou CY, Shi B, Zhang J, Sheng J, Huang H. Alternative splicing of the androgen receptor in polycystic ovary syndrome. Proc Natl Acad Sci U S A. 2015;112(15):4743\u20138.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"12","key":"1454_CR87","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.1210\/jc.2003-030745","volume":"88","author":"MS Coffler","year":"2003","unstructured":"Coffler MS, Patel K, Dahan MH, Yoo RY, Malcom PJ, Chang RJ. Enhanced granulosa cell responsiveness to follicle-stimulating hormone during insulin infusion in women with polycystic ovary syndrome treated with pioglitazone. J Clin Endocrinol Metab. 2003;88(12):5624\u201331.","journal-title":"J Clin Endocrinol Metab."},{"issue":"1-2","key":"1454_CR88","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0303-7207(99)00239-7","volume":"163","author":"S Franks","year":"2000","unstructured":"Franks S, Mason H, Willis D. Follicular dynamics in the polycystic ovary syndrome. Mol Cell Endocrinol. 2000;163(1-2):49\u201352.","journal-title":"Mol Cell Endocrinol."},{"issue":"5","key":"1454_CR89","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.7150\/ijbs.69343","volume":"18","author":"JC Huang","year":"2022","unstructured":"Huang JC, Duan CC, Jin S, Sheng CB, Wang YS, Yue ZP, Guo B. HB-EGF induces mitochondrial dysfunction via estrogen hypersecretion in granulosa cells dependent on cAMP-PKA-JNK\/ERK-Ca(2+)-FOXO1 pathway. Int J Biol Sci. 2022;18(5):2047\u201359.","journal-title":"Int J Biol Sci."},{"issue":"1","key":"1454_CR90","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12958-021-00850-w","volume":"19","author":"YX Wu","year":"2021","unstructured":"Wu YX, Lin YS, Li SC, Yao X, Cheng M, Zhu L, Liu HY. microRNA-194 is increased in polycystic ovary syndrome granulosa cell and induce KGN cells apoptosis by direct targeting heparin-binding EGF-like growth factor. Reprod Biol Endocrinol. 2021;19(1):170.","journal-title":"Reprod Biol Endocrinol."},{"key":"1454_CR91","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40661-017-0039-8","volume":"4","author":"MK Frey","year":"2017","unstructured":"Frey MK, Pothuri B. Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature. Gynecol Oncol Res Pract. 2017;4:4.","journal-title":"Gynecol Oncol Res Pract."},{"issue":"11","key":"1454_CR92","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","volume":"7","author":"DS Tan","year":"2006","unstructured":"Tan DS, Agarwal R, Kaye SB. Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol. 2006;7(11):925\u201334.","journal-title":"Lancet Oncol."},{"issue":"1","key":"1454_CR93","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10555-013-9456-2","volume":"33","author":"B Thibault","year":"2014","unstructured":"Thibault B, Castells M, Delord JP, Couderc B. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition. Cancer Metastasis Rev. 2014;33(1):17\u201339.","journal-title":"Cancer Metastasis Rev."},{"issue":"34","key":"1454_CR94","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1200\/JCO.2005.02.1287","volume":"23","author":"SC Crawford","year":"2005","unstructured":"Crawford SC, Vasey PA, Paul J, Hay A, Davis JA, Kaye SB. Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial. J Clin Oncol. 2005;23(34):8802\u201311.","journal-title":"J Clin Oncol."},{"issue":"8","key":"1454_CR95","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1517\/14656566.2.8.1299","volume":"2","author":"EL Trimble","year":"2001","unstructured":"Trimble EL, Wright J, Christian MC. Treatment of platinum-resistant ovarian cancer. Expert Opin Pharmacother. 2001;2(8):1299\u2013306.","journal-title":"Expert Opin Pharmacother."},{"issue":"8","key":"1454_CR96","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/S1470-2045(15)00086-8","volume":"16","author":"AM Oza","year":"2015","unstructured":"Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon TW, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, et al. Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet Oncol. 2015;16(8):928\u201336.","journal-title":"Lancet Oncol."},{"issue":"3","key":"1454_CR97","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbrc.2007.11.015","volume":"365","author":"F Yotsumoto","year":"2008","unstructured":"Yotsumoto F, Yagi H, Suzuki SO, Oki E, Tsujioka H, Hachisuga T, Sonoda K, Kawarabayashi T, Mekada E, Miyamoto S. Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Biochem Biophys Res Commun. 2008;365(3):555\u201361.","journal-title":"Biochem Biophys Res Commun."},{"issue":"16","key":"1454_CR98","doi-asserted-by":"publisher","first-page":"5720","DOI":"10.1158\/0008-5472.CAN-04-0811","volume":"64","author":"S Miyamoto","year":"2004","unstructured":"Miyamoto S, Hirata M, Yamazaki A, Kageyama T, Hasuwa H, Mizushima H, Tanaka Y, Yagi H, Sonoda K, Kai M, Kanoh H, Nakano H, Mekada E. Heparin-binding EGF-like growth factor is a promising target for ovarian cancer therapy. Cancer Res. 2004;64(16):5720\u20137.","journal-title":"Cancer Res."},{"issue":"9","key":"1454_CR99","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1038\/sj.bjc.6602536","volume":"92","author":"H Yagi","year":"2005","unstructured":"Yagi H, Miyamoto S, Tanaka Y, Sonoda K, Kobayashi H, Kishikawa T, Iwamoto R, Mekada E, Nakano H. Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer. Br J Cancer. 2005;92(9):1737\u201345.","journal-title":"Br J Cancer."},{"issue":"13","key":"1454_CR100","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1158\/1078-0432.CCR-04-1426","volume":"11","author":"Y Tanaka","year":"2005","unstructured":"Tanaka Y, Miyamoto S, Suzuki SO, Oki E, Yagi H, Sonoda K, Yamazaki A, Mizushima H, Maehara Y, Mekada E, Nakano H. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer. Clin Cancer Res. 2005;11(13):4783\u201392.","journal-title":"Clin Cancer Res."},{"issue":"23","key":"1454_CR101","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.3390\/cancers14235867","volume":"14","author":"C Rogmans","year":"2022","unstructured":"Rogmans C, Feuerborn J, Treeck L, Tribian N, Fl\u00f6rkemeier I, Arnold N, Weimer JP, Maass N, Jansen P, Lieb W, Dempfle A, Bauerschlag DO, Hedemann N. Nectin-4 as blood-based biomarker enables detection of early ovarian cancer stages. Cancers (Basel). 2022;14(23):5867. https:\/\/doi.org\/10.3390\/cancers14235867.","journal-title":"Cancers (Basel)."},{"issue":"7","key":"1454_CR102","first-page":"3955","volume":"37","author":"K Miyata","year":"2017","unstructured":"Miyata K, Yotsumoto F, Fukagawa S, Kiyoshima C, Ouk NS, Urushiyama D, Ito T, Katsuda T, Kurakazu M, Araki R, Sanui A, Miyahara D, Murata M, Shirota K, Yagi H, Takono T, Kato K, Yaegashi N, Akazawa K, et al. Serum heparin-binding epidermal growth factor-like growth factor (HB-EGF) as a biomarker for primary ovarian cancer. Anticancer Res. 2017;37(7):3955\u201360.","journal-title":"Anticancer Res."},{"issue":"7","key":"1454_CR103","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.21873\/anticanres.12735","volume":"38","author":"D Izuchi","year":"2018","unstructured":"Izuchi D, Fukagawa S, Yotsumoto F, Shigekawa K, Yoshikawa K, Hirakawa T, Kiyoshima C, Ouk NS, Urushiyama D, Katsuda T, Miyata K, Ito T, Kurakazu M, Araki R, Sanui A, Miyahara D, Murata M, Ito H, Shirota K, et al. Association of serum HB-EGF value and response to chemotherapy in patients with recurrent ovarian cancer. Anticancer Res. 2018;38(7):4347\u201351.","journal-title":"Anticancer Res."},{"issue":"7","key":"1454_CR104","first-page":"2553","volume":"31","author":"S Hikita","year":"2011","unstructured":"Hikita S, Yotsumoto F, Fukami T, Horiuchi S, Sanui A, Miyata K, Nam SO, Tsujioka H, Ueda T, Shirota K, Yoshizato T, Maeda K, Ishikawa T, Okuno Y, Kuroki M, Mekada E, Miyamoto S. Assessment of HB-EGF levels in peritoneal fluid and serum of ovarian cancer patients using ELISA. Anticancer Res. 2011;31(7):2553\u20139.","journal-title":"Anticancer Res."},{"issue":"3","key":"1454_CR105","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1083\/jcb.200307035","volume":"163","author":"S Yamazaki","year":"2003","unstructured":"Yamazaki S, Iwamoto R, Saeki K, Asakura M, Takashima S, Yamazaki A, Kimura R, Mizushima H, Moribe H, Higashiyama S, Endoh M, Kaneda Y, Takagi S, Itami S, Takeda N, Yamada G, Mekada E. Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities. J Cell Biol. 2003;163(3):469\u201375.","journal-title":"J Cell Biol."},{"issue":"1","key":"1454_CR106","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13046-014-0085-6","volume":"33","author":"Y Yu","year":"2014","unstructured":"Yu Y, Zhang M, Zhang X, Cai Q, Zhu Z, Jiang W, Xu C. Transactivation of epidermal growth factor receptor through platelet-activating factor\/receptor in ovarian cancer cells. J Exp Clin Cancer Res. 2014;33(1):85.","journal-title":"J Exp Clin Cancer Res."},{"issue":"1","key":"1454_CR107","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1349-7006.2010.01748.x","volume":"102","author":"N Koshikawa","year":"2011","unstructured":"Koshikawa N, Mizushima H, Minegishi T, Eguchi F, Yotsumoto F, Nabeshima K, Miyamoto S, Mekada E, Seiki M. Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells. Cancer Sci. 2011;102(1):111\u20136.","journal-title":"Cancer Sci."},{"issue":"4","key":"1454_CR108","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1677\/ERC-10-0107","volume":"17","author":"C Bolitho","year":"2010","unstructured":"Bolitho C, Hahn MA, Baxter RC, Marsh DJ. The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor. Endocr Relat Cancer. 2010;17(4):929\u201340.","journal-title":"Endocr Relat Cancer."},{"issue":"5","key":"1454_CR109","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3390\/cells9051299","volume":"9","author":"M Nowak","year":"2020","unstructured":"Nowak M, Klink M. The role of tumor-associated macrophages in the progression and chemoresistance of ovarian cancer. Cells. 2020;9(5):1299. https:\/\/doi.org\/10.3390\/cells9051299.","journal-title":"Cells."},{"issue":"1","key":"1454_CR110","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1038\/s41467-020-20140-0","volume":"11","author":"M Song","year":"2020","unstructured":"Song M, Yeku OO, Rafiq S, Purdon T, Dong X, Zhu L, Zhang T, Wang H, Yu Z, Mai J, Shen H, Nixon B, Li M, Brentjens RJ, Ma X. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages. Nat Commun. 2020;11(1):6298.","journal-title":"Nat Commun."},{"issue":"52","key":"1454_CR111","doi-asserted-by":"publisher","first-page":"86608","DOI":"10.18632\/oncotarget.13474","volume":"7","author":"MJ Carroll","year":"2016","unstructured":"Carroll MJ, Kapur A, Felder M, Patankar MS, Kreeger PK. M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor\/matrix metalloproteinase 9 intercellular feedback loop. Oncotarget. 2016;7(52):86608\u201320.","journal-title":"Oncotarget."},{"issue":"10","key":"1454_CR112","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1158\/1535-7163.MCT-08-0417","volume":"7","author":"H Yagi","year":"2008","unstructured":"Yagi H, Yotsumoto F, Miyamoto S. Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition. Mol Cancer Ther. 2008;7(10):3441\u201351.","journal-title":"Mol Cancer Ther."},{"issue":"5","key":"1454_CR113","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"HZ Hausen","year":"2002","unstructured":"Hausen HZ. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342\u201350.","journal-title":"Nat Rev Cancer."},{"issue":"1","key":"1454_CR114","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12\u20139.","journal-title":"J Pathol."},{"issue":"6","key":"1454_CR115","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","volume":"13","author":"C de Martel","year":"2012","unstructured":"de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012;13(6):607\u201315.","journal-title":"Lancet Oncol."},{"issue":"10","key":"1454_CR116","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1158\/1055-9965.EPI-14-0410","volume":"23","author":"EA Joura","year":"2014","unstructured":"Joura EA, Ault KA, Bosch FX, Brown D, Cuzick J, Ferris D, Garland SM, Giuliano AR, Hernandez-Avila M, Huh W, Iversen OE, Kjaer SK, Luna J, Miller D, Monsonego J, Munoz N, Myers E, Paavonen J, Pitisuttithum P, et al. Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease. Cancer Epidemiol Biomarkers Prev. 2014;23(10):1997\u20132008.","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"7015","key":"1454_CR117","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature03096","volume":"432","author":"NA Bhowmick","year":"2004","unstructured":"Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature. 2004;432(7015):332\u20137.","journal-title":"Nature."},{"issue":"5","key":"1454_CR118","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrc1877","volume":"6","author":"R Kalluri","year":"2006","unstructured":"Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer. 2006;6(5):392\u2013401.","journal-title":"Nat Rev Cancer."},{"issue":"3","key":"1454_CR119","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cell.2005.02.034","volume":"121","author":"A Orimo","year":"2005","unstructured":"Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL, Weinberg RA. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1\/CXCL12 secretion. Cell. 2005;121(3):335\u201348.","journal-title":"Cell."},{"issue":"10","key":"1454_CR120","first-page":"2632","volume":"60","author":"J Fujimoto","year":"2000","unstructured":"Fujimoto J, Sakaguchi H, Aoki I, Tamaya T. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res. 2000;60(10):2632\u20135.","journal-title":"Cancer Res."},{"issue":"1","key":"1454_CR121","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrc1256","volume":"4","author":"JW Pollard","year":"2004","unstructured":"Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4(1):71\u20138.","journal-title":"Nat Rev Cancer."},{"issue":"21","key":"1454_CR122","doi-asserted-by":"publisher","first-page":"6633","DOI":"10.1158\/0008-5472.CAN-11-0034","volume":"71","author":"T Murata","year":"2011","unstructured":"Murata T, Mizushima H, Chinen I, Moribe H, Yagi S, Hoffman RM, Kimura T, Yoshino K, Ueda Y, Enomoto T, Mekada E. HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers. Cancer Res. 2011;71(21):6633\u201342.","journal-title":"Cancer Res."},{"issue":"6","key":"1454_CR123","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.3892\/ijo.2017.3980","volume":"50","author":"M Schrevel","year":"2017","unstructured":"Schrevel M, Osse EM, Prins FA, Trimbos J, Fleuren GJ, Gorter A, Jordanova ES. Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer. Int J Oncol. 2017;50(6):1947\u201354.","journal-title":"Int J Oncol."},{"issue":"3","key":"1454_CR124","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin."},{"issue":"36","key":"1454_CR125","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1200\/JCO.2006.06.5664","volume":"24","author":"BG Haffty","year":"2006","unstructured":"Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, Harris L, Hait W, Toppmeyer D. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol. 2006;24(36):5652\u20137.","journal-title":"J Clin Oncol."},{"issue":"15 Pt 1","key":"1454_CR126","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15 Pt 1):4429\u201334.","journal-title":"Clin Cancer Res."},{"issue":"5812","key":"1454_CR127","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.315.5812.592","volume":"315","author":"J Couzin","year":"2007","unstructured":"Couzin J. Cancer research. Probing the roots of race and cancer. Science. 2007;315(5812):592\u20134.","journal-title":"Science."},{"issue":"2","key":"1454_CR128","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/jcp.20588","volume":"207","author":"N Normanno","year":"2006","unstructured":"Normanno N, De Luca A, Maiello MR, Campiglio M, Napolitano M, Mancino M, Carotenuto A, Viglietto G, Menard S. The MEK\/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. J Cell Physiol. 2006;207(2):420\u20137.","journal-title":"J Cell Physiol."},{"issue":"1","key":"1454_CR129","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/annonc\/mdm431","volume":"19","author":"F Revillion","year":"2008","unstructured":"Revillion F, Lhotellier V, Hornez L, Bonneterre J, Peyrat JP. ErbB\/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis. Ann Oncol. 2008;19(1):73\u201380.","journal-title":"Ann Oncol."},{"issue":"10","key":"1454_CR130","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1515\/cclm-2011-0823","volume":"50","author":"DA Olsen","year":"2012","unstructured":"Olsen DA, Bechmann T, Ostergaard B, Wamberg PA, Jakobsen EH, Brandslund I. Increased concentrations of growth factors and activation of the EGFR system in breast cancer. Clin Chem Lab Med. 2012;50(10):1809\u201318.","journal-title":"Clin Chem Lab Med."},{"issue":"5","key":"1454_CR131","doi-asserted-by":"publisher","first-page":"e97771","DOI":"10.1371\/journal.pone.0097771","volume":"9","author":"M David","year":"2014","unstructured":"David M, Sahay D, Mege F, Descotes F, Leblanc R, Ribeiro J, Clezardin P, Peyruchaud O. Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers. PLoS One. 2014;9(5):e97771.","journal-title":"PLoS One."},{"issue":"3","key":"1454_CR132","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","volume":"123","author":"B Gyorffy","year":"2010","unstructured":"Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, Li Q, Szallasi Z. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. Breast Cancer Res Treat. 2010;123(3):725\u201331.","journal-title":"Breast Cancer Res Treat."},{"issue":"4","key":"1454_CR133","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/0004563216665867","volume":"54","author":"P Shetty","year":"2017","unstructured":"Shetty P, Patil VS, Mohan R, D\u2019souza LC, Bargale A, Patil BR, Dinesh US, Haridas V, Kulkarni SP. Annexin A2 and its downstream IL-6 and HB-EGF as secretory biomarkers in the differential diagnosis of Her-2 negative breast cancer. Ann Clin Biochem. 2017;54(4):463\u201371.","journal-title":"Ann Clin Biochem."},{"issue":"1","key":"1454_CR134","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/A:1010667108371","volume":"67","author":"Y Ito","year":"2001","unstructured":"Ito Y, Takeda T, Higashiyama S, Noguchi S, Matsuura N. Expression of heparin-binding epidermal growth factor-like growth factor in breast carcinoma. Breast Cancer Res Treat. 2001;67(1):81\u20135.","journal-title":"Breast Cancer Res Treat."},{"issue":"1","key":"1454_CR135","doi-asserted-by":"publisher","first-page":"16558","DOI":"10.1038\/s41598-020-72944-1","volume":"10","author":"IM Kjaer","year":"2020","unstructured":"Kjaer IM, Olsen DA, Brandslund I, Bechmann T, Jakobsen EH, Bogh SB, Madsen JS. Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer. Sci Rep. 2020;10(1):16558.","journal-title":"Sci Rep."},{"issue":"1","key":"1454_CR136","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris AL. Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2(1):38\u201347.","journal-title":"Nat Rev Cancer."},{"issue":"3","key":"1454_CR137","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.bbamcr.2015.05.036","volume":"1863","author":"GL Semenza","year":"2016","unstructured":"Semenza GL. The hypoxic tumor microenvironment: a driving force for breast cancer progression. Biochim Biophys Acta. 2016;1863(3):382\u201391.","journal-title":"Biochim Biophys Acta."},{"issue":"7","key":"1454_CR138","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10585-018-9930-x","volume":"35","author":"J Araos","year":"2018","unstructured":"Araos J, Sleeman JP, Garvalov BK. The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies. Clin Exp Metastasis. 2018;35(7):563\u201399.","journal-title":"Clin Exp Metastasis."},{"issue":"19","key":"1454_CR139","doi-asserted-by":"publisher","first-page":"e2020490118","DOI":"10.1073\/pnas.2020490118","volume":"118","author":"R Wang","year":"2021","unstructured":"Wang R, Godet I, Yang Y, Salman S, Lu H, Lyu Y, Zuo Q, Wang Y, Zhu Y, Chen C, He J, Gilkes DM, Semenza GL. Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis. Proc Natl Acad Sci USA. 2021;118(19):e2020490118. https:\/\/doi.org\/10.1073\/pnas.2020490118.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"5","key":"1454_CR140","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/1541-7786.MCR-12-0428","volume":"11","author":"F Yotsumoto","year":"2013","unstructured":"Yotsumoto F, Tokunaga E, Oki E, Maehara Y, Yamada H, Nakajima K, Nam SO, Miyata K, Koyanagi M, Doi K, Shirasawa S, Kuroki M, Miyamoto S. Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancer. Mol Cancer Res. 2013;11(5):506\u201317.","journal-title":"Mol Cancer Res."},{"issue":"1","key":"1454_CR141","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13058-018-1046-3","volume":"20","author":"A Sethuraman","year":"2018","unstructured":"Sethuraman A, Brown M, Krutilina R, Wu ZH, Seagroves TN, Pfeffer LM, Fan M. BHLHE40 confers a pro-survival and pro-metastatic phenotype to breast cancer cells by modulating HBEGF secretion. Breast Cancer Res. 2018;20(1):117.","journal-title":"Breast Cancer Res."},{"issue":"1","key":"1454_CR142","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s13046-019-1359-9","volume":"38","author":"P Song","year":"2019","unstructured":"Song P, Li Y, Dong Y, Liang Y, Qu H, Qi D, Lu Y, Jin X, Guo Y, Jia Y, Wang X, Xu W, Quan C. Estrogen receptor beta inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy. J Exp Clin Cancer Res. 2019;38(1):354.","journal-title":"J Exp Clin Cancer Res."},{"issue":"4","key":"1454_CR143","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1074\/jbc.M205692200","volume":"278","author":"M Razandi","year":"2003","unstructured":"Razandi M, Pedram A, Park ST, Levin ER. Proximal events in signaling by plasma membrane estrogen receptors. J Biol Chem. 2003;278(4):2701\u201312.","journal-title":"J Biol Chem."},{"issue":"10","key":"1454_CR144","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1210\/mend.14.10.0532","volume":"14","author":"EJ Filardo","year":"2000","unstructured":"Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol. 2000;14(10):1649\u201360.","journal-title":"Mol Endocrinol."},{"issue":"8","key":"1454_CR145","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1210\/en.2007-0240","volume":"148","author":"RX Song","year":"2007","unstructured":"Song RX, Zhang Z, Chen Y, Bao Y, Santen RJ. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells. Endocrinology. 2007;148(8):4091\u2013101.","journal-title":"Endocrinology."},{"issue":"9","key":"1454_CR146","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.21873\/anticanres.15229","volume":"41","author":"K Yonemitsu","year":"2021","unstructured":"Yonemitsu K, Miyasato Y, Shiota T, Shinchi Y, Fujiwara Y, Hosaka S, Yamamoto Y, Komohara Y. Soluble factors involved in cancer cell-macrophage interaction promote breast cancer growth. Anticancer Res. 2021;41(9):4249\u201358.","journal-title":"Anticancer Res."},{"key":"1454_CR147","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1471-2407-13-197","volume":"13","author":"P Vlaicu","year":"2013","unstructured":"Vlaicu P, Mertins P, Mayr T, Widschwendter P, Ataseven B, Hogel B, Eiermann W, Knyazev P, Ullrich A. Monocytes\/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator. BMC Cancer. 2013;13:197.","journal-title":"BMC Cancer."},{"issue":"2","key":"1454_CR148","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ygyno.2021.01.036","volume":"161","author":"B Gu","year":"2021","unstructured":"Gu B, Shang X, Yan M, Li X, Wang W, Wang Q, Zhang C. Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990-2019. Gynecol Oncol. 2021;161(2):573\u201380.","journal-title":"Gynecol Oncol."},{"issue":"35","key":"1454_CR149","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1200\/JCO.2016.69.4638","volume":"34","author":"MA Onstad","year":"2016","unstructured":"Onstad MA, Schmandt RE, Lu KH. Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. J Clin Oncol. 2016;34(35):4225\u201330.","journal-title":"J Clin Oncol."},{"issue":"3","key":"1454_CR150","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1210\/jcem.87.3.8350","volume":"87","author":"SL Young","year":"2002","unstructured":"Young SL, Lessey BA, Fritz MA, Meyer WR, Murray MJ, Speckman PL, Nowicki BJ. In vivo and in vitro evidence suggest that HB-EGF regulates endometrial expression of human decay-accelerating factor. J Clin Endocrinol Metab. 2002;87(3):1368\u201375.","journal-title":"J Clin Endocrinol Metab."},{"key":"1454_CR151","doi-asserted-by":"publisher","first-page":"114003","DOI":"10.1016\/j.bcp.2020.114003","volume":"178","author":"R Hoffmann","year":"2020","unstructured":"Hoffmann R, Sarkar Bhattacharya S, Roy D, Winterhoff B, Schmidmaier R, Dredge K, Hammond E, Shridhar V. Sulfated glycolipid PG545 induces endoplasmic reticulum stress and augments autophagic flux by enhancing anticancer chemotherapy efficacy in endometrial cancer. Biochem Pharmacol. 2020;178:114003.","journal-title":"Biochem Pharmacol."},{"issue":"1","key":"1454_CR152","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ygyno.2006.07.015","volume":"104","author":"K Ejskjaer","year":"2007","unstructured":"Ejskjaer K, Sorensen BS, Poulsen SS, Forman A, Nexo E, Mogensen O. Expression of the epidermal growth factor system in endometrioid endometrial cancer. Gynecol Oncol. 2007;104(1):158\u201367.","journal-title":"Gynecol Oncol."},{"issue":"18","key":"1454_CR153","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3390\/cells12182227","volume":"12","author":"G Dixit","year":"2023","unstructured":"Dixit G, Pappas BA, Bhardwaj G, Schanz W, Maretzky T. Functional distinctions of endometrial cancer-associated mutations in the fibroblast growth factor receptor 2 gene. Cells. 2023;12(18):2227. https:\/\/doi.org\/10.3390\/cells12182227.","journal-title":"Cells."},{"issue":"3","key":"1454_CR154","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1074\/jbc.270.3.1015","volume":"270","author":"T Mitamura","year":"1995","unstructured":"Mitamura T, Higashiyama S, Taniguchi N, Klagsbrun M, Mekada E. Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor\/diphtheria toxin receptor and inhibits specifically its mitogenic activity. J Biol Chem. 1995;270(3):1015\u20139.","journal-title":"J Biol Chem."},{"issue":"1","key":"1454_CR155","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/jb\/mvm116","volume":"142","author":"T Kageyama","year":"2007","unstructured":"Kageyama T, Ohishi M, Miyamoto S, Mizushima H, Iwamoto R, Mekada E. Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activity. J Biochem. 2007;142(1):95\u2013104.","journal-title":"J Biochem."},{"issue":"1","key":"1454_CR156","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/jb\/mvq033","volume":"148","author":"M Hamaoka","year":"2010","unstructured":"Hamaoka M, Chinen I, Murata T, Takashima S, Iwamoto R, Mekada E. Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin binding. J Biochem. 2010;148(1):55\u201369.","journal-title":"J Biochem."},{"issue":"8","key":"1454_CR157","first-page":"4615","volume":"34","author":"SO Nam","year":"2014","unstructured":"Nam SO, Yotsumoto F, Miyata K, Suzaki Y, Yagi H, Odawara T, Manabe S, Ishikawa T, Kuroki M, Mekada E, Miyamoto S. Pre-clinical study of BK-UM, a novel inhibitor of HB-EGF, for ovarian cancer therapy. Anticancer Res. 2014;34(8):4615\u201320.","journal-title":"Anticancer Res."},{"issue":"7","key":"1454_CR158","first-page":"3891","volume":"37","author":"S Fukagawa","year":"2017","unstructured":"Fukagawa S, Yotsumoto F, Odawara T, Manabe S, Ishikawa T, Yasunaga S, Miyamoto S. Antitumour effects of intravenous administration of BK-UM, a novel inhibitor of HB-EGF, in ovarian cancer therapy. Anticancer Res. 2017;37(7):3891\u20136.","journal-title":"Anticancer Res."},{"issue":"1","key":"1454_CR159","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12885-017-3071-5","volume":"17","author":"S Miyamoto","year":"2017","unstructured":"Miyamoto S, Yotsumoto F, Ueda T, Fukami T, Sanui A, Miyata K, Nam SO, Fukagawa S, Katsuta T, Maehara M, Kondo H, Miyahara D, Shirota K, Yoshizato T, Kuroki M, Nishikawa H, Saku K, Tsuboi Y, Ishitsuka K, et al. BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study. BMC Cancer. 2017;17(1):89.","journal-title":"BMC Cancer."},{"issue":"7","key":"1454_CR160","first-page":"2461","volume":"31","author":"H Tsujioka","year":"2011","unstructured":"Tsujioka H, Fukami T, Yotsumoto F, Ueda T, Hikita S, Takahashi Y, Kondo H, Kuroki M, Miyamoto S. A possible clinical adaptation of CRM197 in combination with conventional chemotherapeutic agents for ovarian cancer. Anticancer Res. 2011;31(7):2461\u20135.","journal-title":"Anticancer Res."},{"issue":"7","key":"1454_CR161","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ejca.2015.02.007","volume":"51","author":"B Winterhoff","year":"2015","unstructured":"Winterhoff B, Freyer L, Hammond E, Giri S, Mondal S, Roy D, Teoman A, Mullany SA, Hoffmann R, von Bismarck A, Chien J, Block MS, Millward M, Bampton D, Dredge K, Shridhar V. PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples. Eur J Cancer. 2015;51(7):879\u201392.","journal-title":"Eur J Cancer."},{"issue":"10","key":"1454_CR162","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/CAD.0000000000000155","volume":"25","author":"XH Tang","year":"2014","unstructured":"Tang XH, Li M, Deng S, Lu MS. Cross-reacting material 197, a heparin-binding EGF-like growth factor inhibitor, reverses the chemoresistance in human cisplatin-resistant ovarian cancer. Anticancer Drugs. 2014;25(10):1201\u201310.","journal-title":"Anticancer Drugs."},{"issue":"4","key":"1454_CR163","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.bbrc.2012.05.052","volume":"422","author":"XH Tang","year":"2012","unstructured":"Tang XH, Deng S, Li M, Lu MS. The anti-tumor effect of cross-reacting material 197, an inhibitor of heparin-binding EGF-like growth factor, in human resistant ovarian cancer. Biochem Biophys Res Commun. 2012;422(4):676\u201380.","journal-title":"Biochem Biophys Res Commun."},{"issue":"5","key":"1454_CR164","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/cam4.301","volume":"3","author":"K Miyata","year":"2014","unstructured":"Miyata K, Yotsumoto F, Nam SO, Odawara T, Manabe S, Ishikawa T, Itamochi H, Kigawa J, Takada S, Asahara H, Kuroki M, Miyamoto S. Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma. Cancer Med. 2014;3(5):1159\u201369.","journal-title":"Cancer Med."},{"issue":"6","key":"1454_CR165","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/ijc.24031","volume":"124","author":"H Yagi","year":"2009","unstructured":"Yagi H, Yotsumoto F, Sonoda K, Kuroki M, Mekada E, Miyamoto S. Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer. Int J Cancer. 2009;124(6):1429\u201339.","journal-title":"Int J Cancer."},{"issue":"4","key":"1454_CR166","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1007\/s13277-015-4412-0","volume":"37","author":"XH Tang","year":"2016","unstructured":"Tang XH, Deng S, Li M, Lu MS. Cross-reacting material 197 reverses the resistance to paclitaxel in paclitaxel-resistant human ovarian cancer. Tumour Biol. 2016;37(4):5521\u20138.","journal-title":"Tumour Biol."},{"issue":"14","key":"1454_CR167","doi-asserted-by":"publisher","first-page":"6426","DOI":"10.1002\/cam4.2512","volume":"8","author":"XH Tang","year":"2019","unstructured":"Tang XH, Li H, Zheng XS, Lu MS, An Y, Zhang XL. CRM197 reverses paclitaxel resistance by inhibiting the NAC-1\/Gadd45 pathway in paclitaxel-resistant ovarian cancer cells. Cancer Med. 2019;8(14):6426\u201336.","journal-title":"Cancer Med."},{"issue":"6","key":"1454_CR168","doi-asserted-by":"publisher","first-page":"e97897","DOI":"10.1371\/journal.pone.0097897","volume":"9","author":"S Giri","year":"2014","unstructured":"Giri S, Rattan R, Deshpande M, Maguire JL, Johnson Z, Graham RP, Shridhar V. Preclinical therapeutic potential of a nitrosylating agent in the treatment of ovarian cancer. PLoS One. 2014;9(6):e97897.","journal-title":"PLoS One."},{"key":"1454_CR169","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41420-019-0163-9","volume":"5","author":"Y Shen","year":"2019","unstructured":"Shen Y, Ruan L, Lian C, Li R, Tu Z, Liu H. Discovery of HB-EGF binding peptides and their functional characterization in ovarian cancer cell lines. Cell Death Discov. 2019;5:82.","journal-title":"Cell Death Discov."},{"issue":"21","key":"1454_CR170","doi-asserted-by":"publisher","first-page":"6733","DOI":"10.1158\/1078-0432.CCR-11-1029","volume":"17","author":"S Miyamoto","year":"2011","unstructured":"Miyamoto S, Iwamoto R, Furuya A, Takahashi K, Sasaki Y, Ando H, Yotsumoto F, Yoneda T, Hamaoka M, Yagi H, Murakami T, Hori S, Shitara K, Mekada E. A novel anti-human HB-EGF monoclonal antibody with multiple antitumor mechanisms against ovarian cancer cells. Clin Cancer Res. 2011;17(21):6733\u201341.","journal-title":"Clin Cancer Res."},{"issue":"11","key":"1454_CR171","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1002\/ijc.25472","volume":"127","author":"F Yotsumoto","year":"2010","unstructured":"Yotsumoto F, Oki E, Tokunaga E, Maehara Y, Kuroki M, Miyamoto S. HB-EGF orchestrates the complex signals involved in triple-negative and trastuzumab-resistant breast cancer. Int J Cancer. 2010;127(11):2707\u201317.","journal-title":"Int J Cancer."},{"issue":"7","key":"1454_CR172","first-page":"3651","volume":"36","author":"SO Nam","year":"2016","unstructured":"Nam SO, Yotsumoto F, Miyata K, Fukagawa S, Odawara T, Manabe S, Ishikawa T, Kuroki M, Yasunaga S, Miyamoto S. Anti-tumor effect of intravenous administration of CRM197 for triple-negative breast cancer therapy. Anticancer Res. 2016;36(7):3651\u20137.","journal-title":"Anticancer Res."},{"issue":"3","key":"1454_CR173","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s10549-012-2220-4","volume":"135","author":"H Li","year":"2012","unstructured":"Li H, Duhachek-Muggy S, Qi Y, Hong Y, Behbod F, Zolkiewska A. An essential role of metalloprotease-disintegrin ADAM12 in triple-negative breast cancer. Breast Cancer Res Treat. 2012;135(3):759\u201369.","journal-title":"Breast Cancer Res Treat."},{"issue":"12","key":"1454_CR174","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1111\/j.1349-7006.2007.00622.x","volume":"98","author":"S Umemura","year":"2007","unstructured":"Umemura S, Yoshida S, Ohta Y, Naito K, Osamura RY, Tokuda Y. Increased phosphorylation of Akt in triple-negative breast cancers. Cancer Sci. 2007;98(12):1889\u201392.","journal-title":"Cancer Sci."},{"issue":"2","key":"1454_CR175","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jconrel.2011.10.010","volume":"160","author":"K Nishikawa","year":"2012","unstructured":"Nishikawa K, Asai T, Shigematsu H, Shimizu K, Kato H, Asano Y, Takashima S, Mekada E, Oku N, Minamino T. Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer. J Control Release. 2012;160(2):274\u201380.","journal-title":"J Control Release."},{"issue":"4","key":"1454_CR176","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1021\/acs.molpharmaceut.7b01055","volume":"15","author":"A Okamoto","year":"2018","unstructured":"Okamoto A, Asai T, Hirai Y, Shimizu K, Koide H, Minamino T, Oku N. Systemic administration of siRNA with anti-HB-EGF antibody-modified lipid nanoparticles for the treatment of triple-negative breast cancer. Mol Pharm. 2018;15(4):1495\u2013504.","journal-title":"Mol Pharm."},{"issue":"4","key":"1454_CR177","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.bbrc.2014.05.043","volume":"449","author":"A Okamoto","year":"2014","unstructured":"Okamoto A, Asai T, Kato H, Ando H, Minamino T, Mekada E, Oku N. Antibody-modified lipid nanoparticles for selective delivery of siRNA to tumors expressing membrane-anchored form of HB-EGF. Biochem Biophys Res Commun. 2014;449(4):460\u20135.","journal-title":"Biochem Biophys Res Commun."}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-024-01454-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-024-01454-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-024-01454-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T18:07:21Z","timestamp":1726164441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-024-01454-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":177,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["1454"],"URL":"https:\/\/doi.org\/10.1007\/s43032-024-01454-6","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]},"assertion":[{"value":"16 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors approved of participating in this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors approved of the version to be published.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}